Notably, the combination of creatine supplementation with a checkpoint inhibitor blockade treatment, such as the PD-1/PD-L1 blockade, showed a synergistic tumor suppression effect, suggesting that creatine supplementation can be a valuable component for combination cancer immunotherapies. This evidence concerns the gene CD274 and cancer.